Immuneering (IMRX) Other Non-Current Liabilities (2022)
Immuneering (IMRX) recorded quarterly Other Non-Current Liabilities of $9898.0 in Q2 2022, little changed quarter-over-quarter from $9898.0 in Q1 2022.
Immuneering (IMRX) Other Non-Current Liabilities (2022) Analysis & Trends
Immuneering's Other Non-Current Liabilities history runs 1 years deep, the most recent figure standing at $9898.0 for Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Immuneering | 255.40 Mn | 255.40 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 9,898.00 |
| Mar 31, 2022 | 9,898.00 |